InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Piekos Brian, Chief Financial Officer. Insider active across 2 companies, notably Gemini Therapeutics, Inc. /DE. Aggregated, 3 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €120k. History available since 14 May 2021. The latest transaction was filed on 31 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
9,960 shares@ US$1.097.8% of flowCommon StockSEC:0001209191-22-033719:0
7,655 shares@ US$9.46246.1% of flowCommon StockSEC:0000899243-21-019763
Ideal exit: 8 Feb 2022 (T+270)
7,655 shares@ US$9.46246.1% of flowCommon StockSEC:0000899243-21-019763:0
Ideal exit: 8 Feb 2022 (T+270)
3 of 3 declarations
About Piekos Brian
Brian Piekos is the Chief Financial Officer at Gemini Therapeutics, Inc. /DE. He is responsible for the financial management of the company, including financial planning and analysis. His expertise is crucial for ensuring the financial health and compliance of the organization.
